Literature DB >> 30411296

Identification of Differentially Expressed Genes under the Regulation of Transcription Factors in Osteosarcoma.

Yang Liu1, Jianzhong Guan2, Xiaotian Chen1.   

Abstract

The present study was to investigate and identify the differentially expressed genes (DEGs) in the transcriptional regulatory network of osteosarcoma (OS). The gene expression dataset from Gene Expression Omnibus (GEO) datasets was downloaded. DEGs were identified and their functional annotation was also conducted. In addition, differentially expressed transcription factors (TFs) and the regulatory genes were identified. The electronic validation was used to verify the expression of selected genes. The integrated analysis led to 932 DEGs. The results of functional annotation indicated that these DEGs significantly enriched in the p53 signaling pathway, Jak-STAT signaling pathway and Wnt signaling pathway. ZNF354C, NFIC, NFATC2, SP2, FOXO3, EGR1, ZEB1, RREB1, EGR2 and SRF were covered by most TFs. The expression levels of NFIC and EGR2 in electronic validation were compatible with our bio-informatics result. In conclusion, the deregulation of these genes may provide valuable information in understanding the underlying molecular mechanism in the OS.

Entities:  

Keywords:  Differentialy expressed genes; Microarray dataset; Osteosarcoma; Transcription factors

Mesh:

Substances:

Year:  2018        PMID: 30411296     DOI: 10.1007/s12253-018-0519-0

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  46 in total

Review 1.  Cytogenetics and molecular biology of osteosarcoma.

Authors:  Brian D Ragland; Walter C Bell; Robert R Lopez; Gene P Siegal
Journal:  Lab Invest       Date:  2002-04       Impact factor: 5.662

2.  Identification of upstream regulators for synovial expression signature genes in osteoarthritis.

Authors:  Qi Fei; JiSheng Lin; Hai Meng; BingQiang Wang; Yong Yang; Qi Wang; Nan Su; Jinjun Li; Dong Li
Journal:  Joint Bone Spine       Date:  2016-01-29       Impact factor: 4.929

3.  Status of the p53, Rb and MDM2 genes in canine osteosarcoma.

Authors:  S Mendoza; T Konishi; W S Dernell; S J Withrow; C W Miller
Journal:  Anticancer Res       Date:  1998 Nov-Dec       Impact factor: 2.480

4.  Osteomyelosclerosis, anemia and extramedullary hematopoiesis in mice lacking the transcription factor NFATc2.

Authors:  Wolfgang Bauer; Martina Rauner; Michael Haase; Satu Kujawski; Laleh S Arabanian; Ivonne Habermann; Lorenz C Hofbauer; Gerhard Ehninger; Alexander Kiani
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

Review 5.  Unraveling the role of FoxOs in bone--insights from mouse models.

Authors:  Maria Almeida
Journal:  Bone       Date:  2011-06-01       Impact factor: 4.398

6.  FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice.

Authors:  Elena Ambrogini; Maria Almeida; Marta Martin-Millan; Ji-Hye Paik; Ronald A Depinho; Li Han; Joseph Goellner; Robert S Weinstein; Robert L Jilka; Charles A O'Brien; Stavros C Manolagas
Journal:  Cell Metab       Date:  2010-02-03       Impact factor: 27.287

7.  Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.

Authors:  M Unoki; Y Nakamura
Journal:  Oncogene       Date:  2001-07-27       Impact factor: 9.867

8.  A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.

Authors:  Lisa Mirabello; Roelof Koster; Branden S Moriarity; Logan G Spector; Paul S Meltzer; Joy Gary; Mitchell J Machiela; Nathan Pankratz; Orestis A Panagiotou; David Largaespada; Zhaoming Wang; Julie M Gastier-Foster; Richard Gorlick; Chand Khanna; Silvia Regina Caminada de Toledo; Antonio S Petrilli; Ana Patiño-Garcia; Luis Sierrasesúmaga; Fernando Lecanda; Irene L Andrulis; Jay S Wunder; Nalan Gokgoz; Massimo Serra; Claudia Hattinger; Piero Picci; Katia Scotlandi; Adrienne M Flanagan; Roberto Tirabosco; Maria Fernanda Amary; Dina Halai; Mandy L Ballinger; David M Thomas; Sean Davis; Donald A Barkauskas; Neyssa Marina; Lee Helman; George M Otto; Kelsie L Becklin; Natalie K Wolf; Madison T Weg; Margaret Tucker; Sholom Wacholder; Joseph F Fraumeni; Neil E Caporaso; Joseph F Boland; Belynda D Hicks; Aurelie Vogt; Laurie Burdett; Meredith Yeager; Robert N Hoover; Stephen J Chanock; Sharon A Savage
Journal:  Cancer Discov       Date:  2015-06-17       Impact factor: 39.397

9.  Overexpression of transcription factor sp2 inhibits epidermal differentiation and increases susceptibility to wound- and carcinogen-induced tumorigenesis.

Authors:  Tae-Hyung Kim; Shannon L Chiera; Keith E Linder; Carol S Trempus; Robert C Smart; Jonathan M Horowitz
Journal:  Cancer Res       Date:  2010-10-19       Impact factor: 12.701

10.  P53 and beta-catenin activity during estrogen treatment of osteoblasts.

Authors:  Nalini Chandar; Rasleen Saluja; Peter C Lamar; Kevin Kolman; Walter C Prozialeck
Journal:  Cancer Cell Int       Date:  2005-07-29       Impact factor: 5.722

View more
  2 in total

1.  Evaluation of cytotoxic activity and anticancer potential of indigenous Rosemary (Rosmarinus officinalis L.) and Oregano (Origanum vulgare L.) dry extracts on MG-63 bone osteosarcoma human cell line.

Authors:  Cerasela Elena Gîrd; Teodora Costea; Valentina Mitran
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

2.  Development of a novel immune-related genes prognostic signature for osteosarcoma.

Authors:  Zuo-Long Wu; Ya-Jun Deng; Guang-Zhi Zhang; En-Hui Ren; Wen-Hua Yuan; Qi-Qi Xie
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.